Welcome to our dedicated page for ABOVE FOOD INGREIENTS news (Ticker: ABVEF), a resource for investors and traders seeking the latest updates and insights on ABOVE FOOD INGREIENTS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ABOVE FOOD INGREIENTS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ABOVE FOOD INGREIENTS's position in the market.
Above Food Ingredients (OTC: ABVEF) announced a strategic investment totaling US$1,375,000 on August 18, 2026, comprising a US$875,000 secured loan and a US$500,000 convertible debenture. This is described as the first tranche of a potential multi-tranche investment, with any further tranches still to be finalized.
According to Above Food, net proceeds will be used to complete outstanding periodic filings and related audits, support its Nasdaq relisting appeal and hearing review, and fund continued development and commercialization of its core business platforms. The company states it is working closely with auditors and remains committed to pursuing immediate relisting on Nasdaq.
Above Food (OTC: ABVEF) has engaged law firm Dickinson Wright, led by Jacob Frenkel, to represent it in an appeal before the Nasdaq Listing and Hearing Review Council concerning a prior Nasdaq delisting determination.
According to Above Food, it plans to present progress on completing its outstanding periodic filings, emphasize its stated commitment to transparency and regulatory compliance, and note its view that it continues to satisfy other applicable Nasdaq listing requirements. The company is working with advisors and independent auditors to address delayed filings and intends to respond to the Listing Council within the prescribed timeframe.
Above Food also reports receiving an additional Nasdaq notification related to its unfiled Form 20-F for the fiscal year ended January 31, 2026 under Listing Rule 5250(c)(1). The release reiterates numerous forward-looking statements and risks tied to its proposed merger with Palm Global, including regulatory approvals, the ability to list the combined company on Nasdaq, completion of audits and filings, and the possibility the merger may not close, which could trigger a termination fee payable to Palm Global under the merger agreement.
Above Food (OTC: ABVEF) has appealed a Nasdaq delisting determination under Nasdaq Listing Rule 5820(a). The company expects to relist on Nasdaq and aims to meet all listing requirements. Its shares will continue trading on the OTC Market while the Nasdaq Hearing and Review Council reviews the appeal.
Above Food (OTC: ABVEF) announced its common shares now trade on the OTC Market under ABVEF and public warrants under ABVEWF. Shareholders can trade through existing brokers, subject to broker and market rules.
The company remains an SEC-reporting issuer, is working to file audited financials on Form 20-F, and aims to re-list on Nasdaq, including a possible appeal of the Nasdaq delisting decision. A proposed merger with Palm Global remains subject to multiple conditions and may trigger a termination fee if not completed.
Above Food (OTC: ABVEF) announced that its common shares will commence trading on the OTC Over-the-Counter Market under symbol ABVEF, with public warrants trading as ABVEWF.
The company expects to pursue a relisting on Nasdaq by filing audited financial statements on Form 20-F and is reviewing an appeal of the Nasdaq delisting determination.